Pharmacokinetic

Economic Implication of Targeting Higher Trough Level with Extended Half-Life FVIII Prophylaxis

AIM: This analysis aimed to assess the annual International Unit (IU) consumption and costs of prophylaxis therapies with extended half-life recombinant FVIII (EHL-rFVIII), targeting a traditional tro